Method for producing hydrogenated conjugated diene polymer
US-2015368387-A1 · Dec 24, 2015 · US
US9850325B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9850325-B2 |
| Application number | US-201314385582-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2013 |
| Priority date | Mar 16, 2012 |
| Publication date | Dec 26, 2017 |
| Grant date | Dec 26, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing a hydrogenated ring-opening metathesis polymer includes subjecting a cyclic olefin to ring-opening metathesis polymerization in the presence of a polymerization catalyst to produce a ring-opening metathesis polymer, and hydrogenating at least some of carbon-carbon double bonds of the ring-opening metathesis polymer, at least one ruthenium compound selected from a group made of a ruthenium compound represented by a formula (I), (II), (III), and (IV) being used as the polymerization catalyst; and a resin composition having a hydrogenated ring-opening metathesis polymer produced by this method. It is possible to industrially advantageously produce a hydrogenated ring-opening metathesis polymer that exhibits especially excellent light transmittance.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a hydrogenated ring-opening metathesis polymer comprising subjecting a cyclic olefin to ring-opening metathesis polymerization in the presence of a polymerization catalyst to produce a ring-opening metathesis polymer, and hydrogenating at least some of carbon-carbon double bonds of the ring-opening metathesis polymer, the cyclic olefin comprising: (i) a monomer represented by the following formula (2), wherein R 28 is a C 1 -C 20 alkyl group, a C 3 -C 20 cycloalkyl group, a substituted or unsubstituted C 6 -C 20 aryl group, or a group represented by the following formula (3), wherein R 29 is a C 1 -C 3 alkylene group, and R 30 and R 31 are independently a C 1 -C 10 alkyl group or a C 1 -C 10 alkyl halide group, and (ii) a cyclic olefin that includes a protonic polar group, the proportion of the cyclic olefin including a protonic polar group being 10-90 mol % based on the total cyclic olefins, the polymerization catalyst being a ruthenium compound shown by the following formula (I), wherein X 1 and X 2 are independently a halogen atom; L 1 represents a group represented by any of the following formulas (1-1) to (1-3), wherein R 17 and R 18 are independently a phenyl group, 4-methylphenyl group, 2,4-dimethylphenyl group, 2,4,6-trimethylphenyl group, biphenyl group, 1-naphthyl group, 2-naphthyl group, or methylnaphthyl group, R 19 to R 22 are independently a hydrogen atom or a C 1 -C 10 alkyl group, and R 23 to R 25 are independently a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 3 -C 20 cycloalkyl group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, or a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group; R 0 is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyl group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 1 -C 20 alkylsulfonyl group, a C 1 -C 20 alkylsulfinyl group, a formyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, or a di-C 1 -C 20 alkylsulfonylamino group; R 1 is a group represented by (R b1 )(R b2 )NSO 2 —, a formyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a group represented by (R c1 )(R c2 )NCO—, an amide group, a halogen atom, a di-C 1 -C 20 alkylureido group, or a C 1 -C 20 alkylsulfonylamino group, wherein R b1 and R c1 are a hydrogen atom, a C 1 -C 20 alkyl group, or an aryl group, which may be substituted with a halogen atom a C 1 -C 6 alkyl group, C 1 -C 16 alkoxy group, a nitro group, or a cyano group, and R b2 and R c2 are a hydrogen atom, a C 1 -C 20 alkyl group, or an aryl group, which may be substituted with a halogen atom a C 1 -C 6 alkyl group, C 1 -C 16 alkoxy group, a nitro group, or a cyano group, provided that R b1 and R b2 or R c1 and R c2 optionally bond to each other to form a ring; R 2 and R 3 are independently a hydrogen atom, a halogen atom, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryloxy group, a C 6 -C 20 aryl group, a C 2 -C 20 heterocyclic group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, or a C 1 -C 20 alkylsulfonylamino group; R 4 is a hydrogen atom, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyl group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, C 1 -C 6 alkyl group, C 1 -C 6 alkoxy group, a nitro group, or a cyano group, or a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 1 -C 20 alkylsulfonyl group, a C 1 -C 20 alkylsulfinyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, a C 1 -C 20 alkylsulfonylamino group, or a C 6 -C 20 arylcarbonyl group that is optionally substituted with a halogen atom; and Y 1 is an oxygen atom, a sulfur atom, NR b , or PR b , where R b is a hydrogen atom or a C 1 -C 20 alkyl group; wherein the reaction of polymerizing the cyclic olefin by ring-opening metathesis polymerization is conducted in the presence of the polymerization catalyst in an ether-based solvent wherein the ether-based solvent is present in an amount of 0.5-100 parts by weight per one part by weight of the cyclic olefin. 2. The method according to claim 1 , wherein at least 98% of the carbon-carbon double bonds of the ring-opening metathesis polymer are hydrogenated. 3. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-2), wherein L 1 , R 0 , R 2 to R 4 , R b1 , and R b2 are the same as defined in claim 1 . 4. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-3), wherein R 0 , R 2 to R 4 , R 17 , R 18 , R b1 , and R b2 are the same as defined in claim 1 . 5. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-4), wherein R 0 , R 2 to R 4 , R 23 to R 25 , R b1 , and R b2 are the same as defined in claim 1 . 6. A method according to claim 5 , wherein the metathesis polymerization of the cyclic olefin is conducted in the presence of the polymerization catalyst in an ether solvent by a solution polymerization. 7. The method according to claim 2 , wherein the ruthenium compound represented by
Reduction, e.g. hydrogenation · CPC title
TFT applications · CPC title
Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain (C08L7/00 - C08L57/00, C08L61/00 take precedence); Compositions of derivatives of such polymers · CPC title
Use in organic luminescent diodes · CPC title
of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.